Daniela Passeri
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
- Physiology top 5%
Papers in
-
- Asthma and respiratory diseases 3
- Oncology 16
- Drug Transport and Resistance Mechanisms 10
- PARP inhibition in cancer therapy 4
- Co-authors
- Augusto OrlandiRoberto PellicciariFrancesca FrancoElena DoldoGaetana CostanzaMaria Giovanna ScioliAndrea CarottiLuciano Adorini
- Journals
- European Journal of Medicinal Chemistry (4 papers)Clinical Cancer Research (2 papers)Molecular Pharmacology (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Daniela Passeri
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Oncology 381
- Physiology 56
- Geriatrics and Gerontology 47
- Hepatology 80
- Molecular Biology 527
Countries citing papers authored by Daniela Passeri
This map shows the geographic impact of Daniela Passeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Passeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Passeri more than expected).
Fields of papers citing papers by Daniela Passeri
This network shows the impact of papers produced by Daniela Passeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Passeri. The network helps show where Daniela Passeri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniela Passeri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 13 | |
| 3 | 2022 | 16 | |
| 4 | 2022 | 3 | |
| 5 | 2017 | 16 | |
| 6 | 2016 | 37 | |
| 7 | 2015 | 25 | |
| 8 | 2015 | 105 | |
| 9 | 2015 | 10 | |
| 10 | 2014 | 16 | |
| 11 | 2013 | 29 | |
| 12 | 2013 | 22 | |
| 13 | 2013 | 13 | |
| 14 | 2012 | 25 | |
| 15 | 2011 | 29 | |
| 16 | 2011 | 46 | |
| 17 | 2010 | 24 | |
| 18 | Functional Characterization Of The Semi-Synthetic Bile Acid Derivative Int-767, A Dual Fxr And Tgr5 Agonist | 2010 | 1 |
| 19 | 2010 | 156 | |
| 20 | 2005 | 67 |
About Daniela Passeri
Daniela Passeri is a scholar working on Physiology, Oncology, Molecular Biology, Geriatrics and Gerontology and Hepatology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Retinoids in leukemia and cellular processes (6 papers), Cancer therapeutics and mechanisms (5 papers), PARP inhibition in cancer therapy (4 papers), Estrogen and related hormone effects (4 papers), Autophagy in Disease and Therapy (3 papers), Asthma and respiratory diseases (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Oncology (381 citations), Physiology (56 citations), Geriatrics and Gerontology (47 citations), Hepatology (80 citations) and Molecular Biology (527 citations). Daniela Passeri has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Augusto Orlandi, Roberto Pellicciari, Francesca Franco, Elena Doldo, Gaetana Costanza, Maria Giovanna Scioli, Andrea Carotti, Luciano Adorini, Giovanni Rizzo and Mark Pruzanski. Their work appears in journals such as European Journal of Medicinal Chemistry, Clinical Cancer Research, Molecular Pharmacology, Journal of Medicinal Chemistry and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.